President Donald Trump on Monday signed an executive order to incentivize prescription drug manufacturing in the U.S., streamlining the path for pharmaceutical companies to build new production sites ...

Swiss pharmaceutical giant Roche plans to invest $50 billion in the U.S. over the next five years, the latest major spending commitment by a big drugmaker as the industry faces President Trump’s ...

Switzerland-based Roche said it will spend $50B in the U.S. over the next five years and create 12,000 jobs. The investment will fund research and development facilities as well as new manufacturing ...

President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S. The order comes ahead of Trump's planned tariffs on pharmaceuticals imported into the U.S. U.S.